NCT03170440

Brief Summary

In this study, our objective is to determine the effect of two different nerve stimulation types in changing sleep architecture.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
221

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

3 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 23, 2017

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 31, 2017

Completed
5 months until next milestone

Study Start

First participant enrolled

November 1, 2017

Completed
8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2025

Completed
Last Updated

July 1, 2025

Status Verified

June 1, 2025

Enrollment Period

8 years

First QC Date

May 23, 2017

Last Update Submit

June 26, 2025

Conditions

Keywords

Nerve stimulationsleep deprivation

Outcome Measures

Primary Outcomes (1)

  • Physiological sleep architectural quality

    Polysomnography

    up to 8 hours

Study Arms (2)

Noninvasive nerve stimulation type I

EXPERIMENTAL

This group will receive one type of nerve stimulation

Device: Transcutaneous nerve stimulation location 1

Noninvasive nerve stimulation type II

ACTIVE COMPARATOR

This group will receive second type of nerve stimulation

Device: Transcutaneous nerve stimulation location 1

Interventions

Non-invasive stimulation by transcutaneous electrical nerve stimulation device in test location

Noninvasive nerve stimulation type INoninvasive nerve stimulation type II

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • veterans with history of PTSD with and without history of mild TBI

You may not qualify if:

  • history of severe psychiatric illness unrelated to PTSD or TBI
  • other medical conditions of severity that may impair cognition
  • current illicit or prescription drug abuse
  • breathing disorder requiring constant use of oxygen

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

UF Health Jacksonville

Gainesville, Florida, 32608, United States

RECRUITING

University of Florida

Gainesville, Florida, 32610, United States

RECRUITING

UF Health Jacksonville

Jacksonville, Florida, 32209, United States

RECRUITING

MeSH Terms

Conditions

Stress Disorders, Post-TraumaticBrain Injuries, TraumaticSleep Deprivation

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental DisordersBrain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and InjuriesDyssomniasSleep Wake DisordersNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • John Williamson, Ph.D.

    University of Florida

    PRINCIPAL INVESTIGATOR

Central Study Contacts

John Williamson, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 23, 2017

First Posted

May 31, 2017

Study Start

November 1, 2017

Primary Completion

October 30, 2025

Study Completion

October 30, 2025

Last Updated

July 1, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations